OncoSnapTM is a pioneering tumor tissue profiling test which screens for clinically relevant somatic mutations of 130 genes in solid tumor tissues by using NGS technologies, and offers FDA-approved therapies undergoing clinical trials.
Able to detect single nucleotide variations (SNVs), insertions and deletions (indels), selected fusions and copy number alterations
Sample types: FFPE Block or 5μm unstained FFPE slides mounted on slides
Turnaround time: 14 working days upon sample arrival
Why use OncoSnapTM?
99.1% analytical sensitivity
-Detect SNVs, Indels down to 5% VAF, CNAs at ± 2 copies in 130 genes and fusion of selected genes.
Examples of Solid Tumor Can Be Targeted
Head & Neck